Efficacy of dexmedetomidine drug in addition to muscle block for pain relief in spine surgery
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/04/051398
- Lead Sponsor
- Department of Anaesthesia and Intensive Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing thoracolumbar spine surgeries
American Society of Anesthesiologists (ASA) Grade I or II
Body mass index >18 and <35
Exclusion Criteria
History of any drug allergies Pregnancy
coagulopathy
History of substance abuse
Severe cardiovascular, respiratory, neurological or metabolic
disease.
Infection at the planned site.
Chronic analgesia use.
Psychological inability of the patient to understand the QoR -15
questionaire.
Inability to operate a Patient controlled analgesia (PCA) pump.
Psychological inability of the patient to understand Visual Analogue
Scale
baseline heart rate <60bpm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the cumulative morphine consumption over 24 hours study period in patients receiving intravenous dexmedetomidine vis-Ã -vis saline (as placebo) as an adjunct to erector spinae plane blockTimepoint: 24 hours postoperatively
- Secondary Outcome Measures
Name Time Method 1. To evaluate postoperative pain intensity using visual analogue scale (VAS scoring) <br/ ><br>2. Time to first bolus of morphine <br/ ><br>3. Patient satisfaction <br/ ><br>4. Ramsay Sedation scoring <br/ ><br>5. Side effect of the drugs/ technique if anyTimepoint: 1,2,4,6,8,12,24 hours postoperatively